News

We are proud to announce our first investment of 2023! VitalFlo helps leading clinicians and researchers improve patient outcomes and advance lung health by providing comprehensive respiratory data, analysis, and care. VitalFlo helps doctors measure, monitor, and predict their patients’ lung health. The software and data platform makes spirometry fast and easy for primary care doctors and their asthma and COPD patients in any setting: both in-clinic and at-home. The result is better care for patients, less clinical time spent per test, and more revenue for providers via existing insurance reimbursement codes. 

A few highlights regarding recent progress from VitalFlo:

• Dozens of deployments in independent primary care and clinical research settings.
• Launched first health system pulmonary group at Sovah Health, part of a 90-hospital conglomerate. Per Wendy Gilraine, NP, RRT, of Sovah, "I love VitalFlo. I absolutely love it."
• $1.7M+ in National Science Foundation SBIR and other grants and non-dilutive funding.
• $2.1M+ first institutional round in 2021.
• Will be raising second institutional round in 2023.